drugset
drugset / Trial / NCT06203444

An Open-label Study to Evaluate the Pharmacokinetics of Oral Tenapanor in Breast Milk of Lactating Females

NCT06203444 ↗

Phase 1 Completed 7 enrolled Ardelyx
NaSingle-groupOpen-labelTreatment

Summary

This is an open label study to investigate PK of tenapanor and AZ13792925 in breast milk of lactating female subjects.

Timeline

Start
2023-11-27
Primary completion
2024-05-30
Completion
2024-05-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Tenapanor Small molecule 50 mg Oral

Indications

lactation disease